Alpha Teknova Inc
NASDAQ:TKNO

Watchlist Manager
Alpha Teknova Inc Logo
Alpha Teknova Inc
NASDAQ:TKNO
Watchlist
Price: 8.6 USD 11.98% Market Closed
Market Cap: 458.5m USD
Have any thoughts about
Alpha Teknova Inc?
Write Note

Alpha Teknova Inc
Capital Expenditures

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Alpha Teknova Inc
Capital Expenditures Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Capital Expenditures CAGR 3Y CAGR 5Y CAGR 10Y
Alpha Teknova Inc
NASDAQ:TKNO
Capital Expenditures
-$7.9m
CAGR 3-Years
-13%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Thermo Fisher Scientific Inc
NYSE:TMO
Capital Expenditures
-$1.3B
CAGR 3-Years
17%
CAGR 5-Years
-8%
CAGR 10-Years
-14%
Danaher Corp
NYSE:DHR
Capital Expenditures
-$1.3B
CAGR 3-Years
-2%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Mettler-Toledo International Inc
NYSE:MTD
Capital Expenditures
-$95m
CAGR 3-Years
3%
CAGR 5-Years
4%
CAGR 10-Years
-1%
Agilent Technologies Inc
NYSE:A
Capital Expenditures
-$378m
CAGR 3-Years
-26%
CAGR 5-Years
-19%
CAGR 10-Years
-6%
IQVIA Holdings Inc
NYSE:IQV
Capital Expenditures
-$617m
CAGR 3-Years
1%
CAGR 5-Years
-1%
CAGR 10-Years
-24%
No Stocks Found

Alpha Teknova Inc
Glance View

Market Cap
458.4m USD
Industry
Life Sciences Tools & Services

Alpha Teknova, Inc. manufactures cell culture media and supplements. The company is headquartered in Hollister, California and currently employs 231 full-time employees. The company went IPO on 2021-06-25. Its customers include pharmaceutical and biotechnology companies, contract development and manufacturing organizations, in vitro diagnostics franchises, and academic and government research institutions. Its processes enable it to manufacture and deliver custom, made-to-order products across all stages of development, including commercialization. The firm's processes are designed to handle as array of customer-requested inputs, which vary by volume, chemical formulation, quality specifications, container types, and transportation requirements, enabling use of its products across the scope of the life sciences market.

TKNO Intrinsic Value
2.57 USD
Overvaluation 70%
Intrinsic Value
Price

See Also

What is Alpha Teknova Inc's Capital Expenditures?
Capital Expenditures
-7.9m USD

Based on the financial report for Dec 31, 2023, Alpha Teknova Inc's Capital Expenditures amounts to -7.9m USD.

What is Alpha Teknova Inc's Capital Expenditures growth rate?
Capital Expenditures CAGR 3Y
-13%

Over the last year, the Capital Expenditures growth was 72%. The average annual Capital Expenditures growth rates for Alpha Teknova Inc have been -13% over the past three years .

Back to Top